Concepedia

Marilyne Lavergne

ML

Statistics

Publications

5

Citations

205

H-Index

5

Active since

2017

Affiliations

Inserm(Current)

Centre Hospitalier Universitaire de Clermont-Ferrand

Centre National de la Recherche Scientifique

Université Clermont Auvergne

Clermont Université

Marilyne Lavergne is an author at Inserm specializing in life sciences, molecular biology, and advanced glycation end products.

ORCID

Publications per year

2017–2021

5

Publications

5

RAGE inhibition reduces acute lung injury in mice

Raïko Blondonnet, Jules Audard, Corinne Belville et al. · Scientific Reports · 2017 · 125 citations · Full text

, , +17

Inhibition of the Receptor for Advanced Glycation End-Products in Acute Respiratory Distress Syndrome: A Randomised Laboratory Trial in Piglets

Jules Audard, Thomas Godet, Raïko Blondonnet et al. · Scientific Reports · 2019 · 35 citations · Full text

, , +15

Occurrence of a RAGE-Mediated Inflammatory Response in Human Fetal Membranes

Hélèna Choltus, Marilyne Lavergne, Corinne Belville et al. · Frontiers in Physiology · 2020 · 18 citations · Full text

, , +17

A Profound Membrane Reorganization Defines Susceptibility of Plasmodium falciparum Infected Red Blood Cells to Lysis by Granulysin and Perforin

María Andrea Hernández-Castañeda, Marilyne Lavergne, Pierina Casanova et al. · Frontiers in Immunology · 2021 · 15 citations · Full text

, , +17

Advanced Glycation End Products and Receptor (RAGE) Promote Wound Healing of Human Corneal Epithelial Cells

Christelle Gross, Corinne Belville, Marilyne Lavergne et al. · Investigative Ophthalmology & Visual Science · 2020 · 12 citations · Full text

, , +15

1–5 of 5